|
Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
| 4.215 USD | +13.00% |
|
+13.07% | +24.48% |
| 14/07 | Ironwood Pharmaceuticals, Inc. Announces Management Changes | CI |
| 27/05 | Ironwood Says US FDA Approves Linzess Use in Children Aged Two Years and Older With Functional Constipation | MT |
| Market Cap | 61Cr 53Cr 50Cr 46Cr 86Cr 5.86TCr 87Cr 585.61Cr 229.84Cr 2.92TCr 230.6Cr 225.53Cr 9.78TCr | P/E 2026 * |
3.15x | P/E 2027 * | 3.02x |
|---|---|---|---|---|---|
| Enterprise Value | 61Cr 53Cr 50Cr 46Cr 86Cr 5.86TCr 87Cr 585.61Cr 229.84Cr 2.92TCr 230.6Cr 225.53Cr 9.78TCr | EV / Sales 2026 * |
1.33x | EV / Sales 2027 * | 1.28x |
| Free-Float |
96.75% | Yield 2026 * |
-
| Yield 2027 * | - |
Last Transcript: Ironwood Pharmaceuticals, Inc.
| 1 day | +13.00% | ||
| 1 week | +13.07% | ||
| Current month | -0.36% | ||
| 1 month | +1.82% | ||
| 3 months | -5.52% | ||
| 6 months | -15.08% | ||
| Current year | +24.48% |
| 1 week | 3.55 |  | 4.28 |
| 1 month | 3.55 | | 4.88 |
| Current year | 2.95 | | 5.78 |
| 1 year | 0.72 | | 5.78 |
| 3 years | 0.53 | | 15.7 |
| 5 years | 0.53 | | 15.7 |
| 10 years | 0.53 | | 21.2 |
| Manager | Title | Age | Since |
|---|---|---|---|
Thomas McCourt
CEO | Chief Executive Officer | 68 | 12/03/2021 |
Ronald Silver
DFI | Director of Finance/CFO | 44 | 15/05/2026 |
Jeffrey Silber
CTO | Chief Tech/Sci/R&D Officer | - | 20/07/2026 |
| Director | Title | Age | Since |
|---|---|---|---|
Thomas McCourt
BRD | Director/Board Member | 68 | 04/06/2021 |
Julie McHugh
CHM | Chairman | 61 | 01/04/2019 |
Marla Kessler
BRD | Director/Board Member | 56 | 01/04/2019 |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | |
|---|---|---|---|---|---|---|
| 20/07/26 | Free | Chief Technology Officer | 1,37,036 | 0.0832% | ||
| 07/07/26 | Sell | Chief Financial Officer | -1,27,890 | 0.0777% | ||
| 23/02/26 | Sell | Chief Executive Officer | 1,98,283 | 0.1219% |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | +13.00% | +13.07% | +449.08% | -62.17% | 61Cr | |
| +0.60% | -0.24% | +67.38% | +22.61% | 32TCr | |
| +0.21% | +2.87% | +29.78% | -10.42% | 7.15TCr | |
| -0.56% | +1.31% | +38.41% | +93.21% | 988.05Cr | |
| -3.60% | -1.52% | -0.43% | -5.11% | 870Cr | |
| +1.80% | -0.88% | -20.84% | -3.30% | 425.44Cr | |
| -0.68% | +2.94% | -38.65% | +11.36% | 386.28Cr | |
| +3.08% | -5.35% | -9.43% | +0.75% | 347.02Cr | |
| -2.13% | -3.79% | +26.64% | +44.84% | 264.72Cr | |
| +0.85% | +5.41% | -3.94% | -4.52% | 222.54Cr | |
| Average | +1.20% | +1.02% | +53.80% | +8.72% | 4.28TCr | |
| Weighted average by Cap. | +0.40% | +4.46% | +56.52% | +17.49% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | 46Cr 40Cr 37Cr 34Cr 65Cr 4.39TCr 66Cr 438.85Cr 172.23Cr 2.19TCr 172.8Cr 169.01Cr 7.33TCr | 48Cr 42Cr 39Cr 36Cr 67Cr 4.57TCr 68Cr 456.23Cr 179.06Cr 2.27TCr 179.65Cr 175.7Cr 7.62TCr |
| Net income | 18Cr 16Cr 15Cr 13Cr 25Cr 1.73TCr 26Cr 173.2Cr 68Cr 863.04Cr 68Cr 67Cr 2.89TCr | 21Cr 18Cr 17Cr 16Cr 29Cr 2TCr 30Cr 200.16Cr 79Cr 997.38Cr 79Cr 77Cr 3.34TCr |
| Net Debt | - | - |
| Date | Price | Change | Volume |
|---|---|---|---|
| 01/26/01 | $4.205 | +12.73% | 29,65,117 |
| 30/26/30 | $3.730 | +4.78% | 12,99,350 |
| 29/26/29 | $3.560 | -6.32% | 12,52,812 |
| 28/26/28 | $3.800 | -2.81% | 18,21,245 |
| 27/26/27 | $3.910 | +5.39% | 19,30,760 |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.
Quarterly revenue - Rate of surprise
- Stock Market
- Stocks
- IRWD Stock
Select your edition
All financial news and data tailored to specific country editions
